fibrinogen has been researched along with Compensatory Hyperinsulinemia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilić-Ćurčić, I; Franceschi, M; Jukić, T; Makarović, S; Mihaljević, I | 1 |
| Baiocchi, MR; Coracina, A; Kiwanuka, E; Millioni, R; Puricelli, L; Semplicini, A; Tessari, P; Vettore, M; Zaramella, M | 1 |
| Bruehl, H; Convit, A; Javier, E; Lee, C; Reddy, S; Sweat, V; Tirsi, A; Tsui, W | 1 |
| Grant, PJ | 1 |
| Angeloni, SV; Hansen, BC; Selaru, IK; Tigno, XT | 1 |
| Baxi, H; Chag, M; Chandarana, A; Goyal, R; Mehta, A; Naik, A; Parikh, K; Shah, K; Shah, U | 1 |
| Després, JP; Lemieux, I; Mertens, I; Van Gaal, LF; Verrijken, A | 1 |
| Asplund, K; Eliasson, M; Evrin, PE; Lindahl, B; Lundblad, D | 1 |
| Catapano, G; Di Bello, V; Ferrari, M; Giusti, C; Materazzi, F; Melillo, E; Mosca, F; Pedrinelli, R; Santoro, G; Talarico, L | 1 |
| Bolli, GB; Brunetti, P; Cruciani, G; De Feo, P; Lucidi, P; Monacchia, F; Reboldi, G; Volpi, E | 1 |
| Abramov, N; Blieden, LC; Gil-Ad, I; Goez, R; Kuberger, N; Laron, Z; Weizman, A | 1 |
| Dinesen, B; Eliasson, M; Evrin, PE; Lindahl, B; Røder, ME | 1 |
| Channer, KS; English, KM; Jones, TH; Steeds, R | 1 |
| Desaive, C; Dewe, W; Gielen, JE; Lefebvre, PJ; Luyckx, FH; Scheen, AJ | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Hales, CN; Mykkänen, L; Tracy, RP; Zaccaro, DJ | 1 |
| Binz, JG; Brown, HR; Gaskill, BA; Lancaster, ME; Lenhard, JM; Lightfoot, RM; Paulik, MA; Sundseth, SS; Weiel, JE | 1 |
| Aïssa-Benhaddad, A; Brun, J; Fédou, C; Mercier, J; Pérez-Martin, A; Raynaud, E | 1 |
| Brun, JF; Dumortier, M; Mercier, J; Pérez-Martin, A; Pierrisnard, E; Raynaud, E | 1 |
2 review(s) available for fibrinogen and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
The genetics of atherothrombotic disorders: a clinician's view.
Topics: Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Factor VII; Factor XII; Fibrinogen; Humans; Hyperinsulinism; Hypertension; Inflammation; Insulin Resistance; Models, Biological; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 2003 |
Testosterone and coronary heart disease: is there a link?
Topics: Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Hyperinsulinism; Male; Myocardial Infarction; Obesity; Risk Factors; Smoking; Testosterone | 1997 |
1 trial(s) available for fibrinogen and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia.
Topics: Apolipoprotein A-I; Apolipoproteins B; Atorvastatin; Blood Glucose; Body Mass Index; Cholesterol, HDL; Coronary Artery Disease; Diabetes Complications; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Antagonists; Male; Middle Aged; Pioglitazone; Pyrroles; Thiazolidinediones; Treatment Outcome | 2007 |
15 other study(ies) available for fibrinogen and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Bone Mineral Density in Relation to Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2
Topics: Aged; Biomarkers; Body Mass Index; Bone Density; C-Reactive Protein; Collagen; Diabetes Mellitus, Type 2; Female; Femur; Fibrinogen; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Metabolic Syndrome; Middle Aged; Obesity; Obesity, Abdominal; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Plasminogen Activator Inhibitor 1; Postmenopause; Spine; Waist Circumference | 2017 |
Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin.
Topics: Adult; Biomarkers; Blood Glucose; Case-Control Studies; Deuterium; Fibrinogen; Glucose; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypertension; Indicator Dilution Techniques; Infusions, Intravenous; Insulin; Kinetics; Leucine; Male; Middle Aged; Peptide Hydrolases; Up-Regulation | 2009 |
Retinal vessel abnormalities are associated with elevated fasting insulin levels and cerebral atrophy in nondiabetic individuals.
Topics: Adult; Aged; Atrophy; Blood Glucose; Blood Pressure; Body Mass Index; Brain; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Magnetic Resonance Imaging; Male; Middle Aged; Photography; Retinal Vessels | 2009 |
Is microvascular flow rate related to ghrelin, leptin and adiponectin levels?
Topics: Adiponectin; Animals; Blood Glucose; Fibrinogen; Ghrelin; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypolipidemic Agents; Intercellular Signaling Peptides and Proteins; Leptin; Macaca mulatta; Metabolic Syndrome; Microcirculation; Obesity; Peptide Hormones; Prediabetic State; Proteins | 2003 |
PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
Topics: Aged; Apolipoproteins B; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperinsulinism; Intra-Abdominal Fat; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Phenotype; Plasminogen Activator Inhibitor 1; Tomography, X-Ray Computed; von Willebrand Factor | 2008 |
Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.
Topics: Adult; Analysis of Variance; Anthropometry; Blood Glucose; Blood Pressure; Female; Fibrinogen; Humans; Hyperinsulinism; Insulin; Linear Models; Male; Menopause; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Tissue Plasminogen Activator | 1994 |
Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients.
Topics: Administration, Oral; Aged; Albuminuria; Angiography; Arteriosclerosis; Blood Glucose; Blood Pressure; C-Peptide; Echocardiography; Fibrinogen; Glucose; Humans; Hyperinsulinism; Hypertrophy, Left Ventricular; Insulin; Lipids; Male; Middle Aged; Peripheral Vascular Diseases | 1993 |
Contribution of amino acids and insulin to protein anabolism during meal absorption.
Topics: Administration, Oral; Adult; Amino Acids; Antithrombin III; Blood Glucose; C-Peptide; Carbon Radioisotopes; Eating; Fatty Acids, Nonesterified; Female; Fibrinogen; Glucagon; Glucose; Humans; Hyperinsulinism; Immunoglobulin G; Insulin; Intestinal Absorption; Keto Acids; Kinetics; Leucine; Lipid Metabolism; Lipids; Male; Protein Biosynthesis; Proteins; Radioisotope Dilution Technique; Serum Albumin | 1996 |
Non-traditional risk factors for atherosclerosis in high risk children.
Topics: Adolescent; Adult; Arteriosclerosis; Autonomic Nervous System Diseases; Case-Control Studies; Child; Electrocardiography, Ambulatory; Female; Fibrinogen; Humans; Hyperinsulinism; Hyperlipoproteinemias; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombosis | 1996 |
Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.
Topics: Adult; Aged; Cardiovascular Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolysis; Glucose Intolerance; Humans; Hyperinsulinism; Insulin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Random Allocation; Risk Factors; Sweden; Tissue Plasminogen Activator | 1997 |
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity.
Topics: Adult; Belgium; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Cohort Studies; Comorbidity; Female; Fibrinogen; Follow-Up Studies; Gastroplasty; Humans; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Insulin; Insulin Resistance; Male; Obesity, Morbid; Prevalence; Severity of Illness Index; Triglycerides; Uric Acid; Weight Loss | 1998 |
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Arteriosclerosis; Asian People; Black People; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Regression Analysis; Risk Factors; White People | 1999 |
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.
Topics: Animals; Blood Glucose; Cachexia; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Fibrinogen; Glycated Hemoglobin; Hepatomegaly; Hyperinsulinism; Islets of Langerhans; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Risk Factors; Tetrahydronaphthalenes; Transcription Factors | 1999 |
Relationships between fibrinogen and insulin resistance.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Middle Aged; Prognosis; Radioimmunoassay | 2000 |
Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance?
Topics: Adult; Biomarkers; Blood Glucose; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Aggregation; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Hemorheology; Homeostasis; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Lipids; Male; Multivariate Analysis; Risk Factors | 2001 |